[Updating deep venous thrombosis. II. Prevention and therapy].
Antignani
P L
PL
Sanguigni
S
S
D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D003911:Dextrans / Q000008:administration & dosage; D004087:Dihydroergotamine / Q000008:administration & dosage; D005343:Fibrinolytic Agents / Q000008:administration & dosage; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D011183:Postoperative Complications / Q000188:drug therapy / Q000517:prevention & control; D013300:Streptokinase / Q000008:administration & dosage; D013924:Thrombophlebitis / Q000188:drug therapy* / Q000517:prevention & control*; D013997:Time Factors; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage
D003911:Dextrans; D005343:Fibrinolytic Agents; D004087:Dihydroergotamine; D006493:Heparin; D013300:Streptokinase; D014568:Urokinase-Type Plasminogen Activator
Attualità in tema di trombosi venosa profonda. Parte II. Profilassi e terapia.